Premier, a major U.S. healthcare-services and supply-chain company, has been acquired by Patient Square Capital for US $2.6 billion in a take-private deal. Under the agreement, shareholders receive US $28.25 per share in cash, and Premier will now operate as a wholly owned subsidiary, giving it fresh capital and flexibility to expand tech-enabled services for hospitals and life-sciences providers.
Glimpse:
Premier, long listed on Nasdaq, will cease public trading as of 25 Nov 2025. The acquisition first announced in September 2025 and closing earlier than initially expected is supported by overwhelming shareholder approval (~99 % of votes cast). Premier’s board resigned under the acquisition terms; company leadership remains in place as directors under Patient Square ownership.
U.S.-based healthcare-services firm Premier, which provides supply-chain solutions, data analytics, consulting, and operational tools to hospitals and life-sciences organizations, has officially been taken private by Patient Square Capital, a PE firm focused on the healthcare sector. The deal, valued at US $2.6 billion, was completed on 25 Nov 2025.
Under the terms, Premier stockholders received US $28.25 per share a premium to its recent trading price and the company’s common stock stopped trading on Nasdaq the same day.
The acquisition was preceded by a strategic shift: in 2023 Premier initiated a review of strategic alternatives, sold non-healthcare assets to refocus on core operations, and reoriented around its supply-chain, technology, and health-service offerings.
With private-ownership and fresh capital, Patient Square Capital citing confidence in Premier’s potential aims to invest in technology, data-driven health services, and expanded supply-chain capabilities. The move reflects growing investor appetite for consolidating and transforming health-services providers in a dynamic U.S. healthcare market. Premier’s CEO, the transition to private ownership will give the company greater financial flexibility to accelerate its “tech-enabled product portfolio,” invest in emerging opportunities, and adapt to evolving challenges in healthcare supply-chain, cost pressures, and digital transformation.
“Transitioning to private ownership will enable us to enhance financial flexibility and accelerate our investments in technology and services helping us better serve hospitals, health-systems and life-science organizations during a critical phase in U.S. healthcare.”
By
HB Team
Related News
